Document is current
Any future updates will be listed below
-
Authors
Imaoka, Hiroshi http://orcid.org/0000-0003-0584-0095
Ikeda, Masafumi
Maehara, Kosuke
Umemoto, Kumiko
Ozaka, Masato
Kobayashi, Satoshi
Terashima, Takeshi
Inoue, Hiroto
Sakaguchi, Chihiro
Tsuji, Kunihiro
Shioji, Kazuhiko
Okamura, Keiya
Kawamoto, Yasuyuki
Suzuki, Rei
Shirakawa, Hirofumi
Nagano, Hiroaki
Ueno, Makoto
Morizane, Chigusa
Furuse, Junji
-
Funding
Funding for this research was provided by:
National Cancer Center Research and Development Fund (29-A-3)
- License Information
-
More Information
Article History
Received: 15 July 2020
Accepted: 25 September 2020
First Online: 1 October 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of National Cancer Center (reference number, 2018–242). Approval for the review of hospital records was obtained from the Institutional Review Board of National Cancer Center and the patients’ informed consent was waived given the retrospective nature of the study.
: Not applicable.
: Yasuyuki Kawamoto has received speaking honoraria from Taiho Pharmaceutical and Lilly. Makoto Ueno has received research funding from Taiho Pharmaceutical and Yakult Honsha, and speaking honoraria from Taiho Pharmaceutical and Yakult Honsha. The other authors have no conflict of interest.
